Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiwa M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Kaytross Health Care

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimiwa M 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and trembling, and know how to counteract them with a fast-acting glucose source (e.g., sugary foods, fruit juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any heart history before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose checks and potential blood tests to monitor blood cell counts and liver function are necessary.

Uses of Glimiwa M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiwa M 2mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Glimiwa M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glimiwa M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiwa M 2mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimiwa M 2mg/500mg Tablet with a meal.

How Glimiwa M 2mg/500mg Tablet works:

Glimiwa M 2mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glimiwa M 2mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimiwa M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimiwa M 2mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with either hypo- or hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimiwa M 2mg/500mg tablets, as dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimiwa M 2mg/500mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiwa M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimiwa M 2mg/500mg Tablet :

Should you forget a Glimiwa M 2mg/500mg Tablet dose, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiwa M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimiwa M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimiwa M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Glimiwa M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimiwa M 2mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimiwa M 2mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimiwa M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimiwa M 2mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimiwa M 2mg/500mg Table...
44
MRP 51
13% off